Florida Medical Weight Loss

Florida Medical Weight Loss We specialize in Medical Weight Loss using both Tirzepatide and Semaglutide plus adjunct medications Welcome to FLORIDA MEDICAL INC.

Semaglutide and Tirzepatide, in addition to their use for type 2 diabetes management, have also demonstrated significant efficacy in promoting weight loss. There are notable differences between the two in their effects on weight reduction. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved at a higher dose specifically for the treatment of obesity. It has shown remarkable weight loss results in clinical trials, with patients experiencing substantial reductions in body weight. Patients who coupled Semaglutide doses with better diets and exercise lost on average 15% of their initial weight. On the other hand, tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that has shown even more promising results in terms of weight loss. Clinical studies have reported greater reductions in body weight with Tirzepatide compared to Semaglutide. People taking Tirzepatide lost, on average, 22% of their starting weight

Address

4651 Sheridan Street Suite # 220
Hollywood, FL
33021

Website

Alerts

Be the first to know and let us send you an email when Florida Medical Weight Loss posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category